Literature DB >> 9053030

Adoptive immunotherapy of cancer with activated lymph node cells primed in vivo with autologous tumor cells transduced with the GM-CSF gene.

A E Chang1, V K Sondak, D K Bishop, B J Nickoloff, R C Mulligan, J J Mulé.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1996        PMID： 9053030     DOI： 10.1089/hum.1996.7.6-773

Source DB:  PubMed          Journal:  Hum Gene Ther        ISSN： 1043-0342            Impact factor:   5.695


× No keyword cloud information.
  2 in total

1.  Melanoma vaccines: clinical status and immune endpoints.

Authors:  Deena M Maurer; Lisa H Butterfield; Lazar Vujanovic
Journal:  Melanoma Res       Date:  2019-04       Impact factor: 3.599

2.  Tumor-induced immune suppression of in vivo effector T-cell priming is mediated by the B7-H1/PD-1 axis and transforming growth factor beta.

Authors:  Shuang Wei; Andrew B Shreiner; Nobuhiro Takeshita; Lieping Chen; Weiping Zou; Alfred E Chang
Journal:  Cancer Res       Date:  2008-07-01       Impact factor: 12.701
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.